↓ Skip to main content

Methylphenidate increases cigarette smoking in participants with ADHD

Overview of attention for article published in Psychopharmacology, May 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy
1 policy source
twitter
5 X users
q&a
1 Q&A thread

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
81 Mendeley
Title
Methylphenidate increases cigarette smoking in participants with ADHD
Published in
Psychopharmacology, May 2011
DOI 10.1007/s00213-011-2328-y
Pubmed ID
Authors

Andrea R. Vansickel, William W. Stoops, Paul E. A. Glaser, Megan M. Poole, Craig R. Rush

Abstract

Methylphenidate (Ritalin®) is commonly prescribed for behavioral problems associated with attention deficit/hyperactivity disorder (ADHD). The results of previous studies suggest that methylphenidate increases cigarette smoking in participants without psychiatric diagnoses. Whether methylphenidate increases cigarette smoking in participants diagnosed with ADHD is unknown.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Brazil 1 1%
Unknown 79 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 19%
Student > Bachelor 14 17%
Researcher 10 12%
Student > Ph. D. Student 7 9%
Unspecified 6 7%
Other 16 20%
Unknown 13 16%
Readers by discipline Count As %
Psychology 19 23%
Medicine and Dentistry 15 19%
Agricultural and Biological Sciences 7 9%
Unspecified 6 7%
Business, Management and Accounting 4 5%
Other 13 16%
Unknown 17 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2023.
All research outputs
#3,734,884
of 25,498,750 outputs
Outputs from Psychopharmacology
#911
of 5,339 outputs
Outputs of similar age
#17,900
of 123,746 outputs
Outputs of similar age from Psychopharmacology
#10
of 33 outputs
Altmetric has tracked 25,498,750 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,339 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,746 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.